AZD-2820

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAZD-2820
Drug Alias NameAZD-2820
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionMelanocortin receptor 4 agonists
TargetsMelanocortin receptor 4
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca PlcPalatin Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A